Yervoy

NICE: Bristol-Myers Squibb’s Yervoy too costly

October 14, 2011
Sales and Marketing NICE, Yervoy

Bristol Myers Squibb has failed to win NICE backing for its melanoma drug Yervoy after the Institute judged its £80,000 …

Avastin

NHS regions back Avastin for eye disease

October 14, 2011
Sales and Marketing avastin

Regional NHS authorities around England are approving the use of Avastin instead of Lucentis for ophthalmology patients. A number of …

Kindle Fire

Keep taking the tablets

October 13, 2011
Sales and Marketing ipad, tablet pc

Online giant Amazon has just launched Fire, its rival to Apple’s trendsetting iPad, upping the ante in the ‘tablet’ market. …

Roche

Roche revenue drops as key products underperform

October 13, 2011
Sales and Marketing Roche

Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …

NICE recommends RoActemra for early use in arthritis

October 13, 2011
Sales and Marketing NICE, RoActemra

NICE has recommended Roche’s drug RoActemra be used at an earlier stage for some arthritis patients. In draft guidance NICE …

Lords’ Health Bill challenge fails

October 12, 2011
NHS reform

The government’s NHS reforms have survived a challenge in the House of Lords that have delayed them until the next …

Bayer planning joint venture to make drugs in Russia

October 12, 2011
Manufacturing and Production Bayer, pharma manufacturing news

Germany’s Bayer AG has joined a number of its peers in the pharmaceutical industry with the signing of an agreement …

Europe

Pharmacovigilance at heart of EC patient information proposals

October 12, 2011
Medical Communications, Sales and Marketing patient information

Pharmacovigilance is at the centre of revised proposals announced this week setting out what information pharma firms can put on …

Charities support new electronic patient records

October 12, 2011
Sales and Marketing IT, NHS, electronic patient records

The troubled project to launch an NHS-wide electronic patient record system has received new support from patient groups.The Summary Care …

Quintiles opens new European headquarters in the UK

October 12, 2011
Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …

Peers to vote on delaying the Health Bill

October 12, 2011
NHS reforms

The government’s health reforms face the prospect of a significant delay if a vote today goes against them. Peers in …

MS audit finds little improvement in care

October 12, 2011
MS, multiple sclerosis

There has been “little or no improvement” in the care of multiple sclerosis patients over the past five years, according …

Pharma manufacturing news in brief

October 12, 2011
Manufacturing and Production pharma manufacturing news

FDA sets aside $35m for manufacturing research, Anteco, Apicore and Vetter provide facility updates and Domino Printing sets up a …

Stallergenes Moves to the Cloud with Veeva CRM

October 11, 2011

BARCELONA, SPAIN — 11 October, 2011 – Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace …

India

India will scrutinise foreign investment in pharma

October 11, 2011
Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry

The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …

Parexel to work with Singapore on clinical research training

October 11, 2011
Research and Development Asia, CRO, Parexel, Singapore, clinical research

Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …

Mike Farrar

‘Paralysis’ in NHS if reforms passed

October 11, 2011
Andrew Lansley, Health and Social Care Bill, Mike Farrar, NHS

A prominent NHS leader has warned the government’s reforms are unworkable in their current form. NHS Confederation chief executive Mike …

AstraZeneca plans $200m manufacturing plant in China

October 11, 2011
Manufacturing and Production AstraZeneca, China, pharma manufacturing news

AstraZeneca has announced plans to set up a manufacturing facility in north-eastern China, backed by a record investment by the …

Pfizer taps into Saudi stimulus package with new plant

October 10, 2011
Manufacturing and Production Pfizer, pharma manufacturing news

Pfizer has unveiled expansion plans for the Middle East region with an agreement to open a manufacturing plant in Saudi …

Victoza

Novo Nordisk’s Victoza launched in China

October 10, 2011
Sales and Marketing Byetta, China, Victoza, diabetes

Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …

The Gateway to Local Adoption Series

Latest content